Latest Documents


  • 9-September-2016

    English

    Global Action to Drive Innovation in Alzheimer's Disease and Other Dementias: Connecting Research, Regulation and Access

    A December 2015 workshop in Lausanne reviewed the policy and stakeholder actions needed to accelerate biomedical research and health innovation for Alzheimer’s disease and other dementias. There is consensus across all stakeholders to move from global agenda setting in Alzheimer’s disease to action oriented programmes and implementation.

  • 22-April-2015

    English

    Enhancing Translational Research and Clinical Development for Alzheimer's Disease and other Dementias

    Accelerating innovation for Alzheimer’s disease and other dementias is a key challenge. An OECD workshop in November 2014 provided an international forum for all stakeholders to drive forward a change in the global paradigm in biomedical research and health innovation for Alzheimer’s disease and other dementias.

  • 9-April-2015

    English

    Public-private Partnerships in Biomedical Research and Health Innovation for Alzheimer's Disease and other Dementias

    This report looks at the roles and options of stakeholders (governments, regulatory agencies, academia, small and mid-size biotech companies, the pharmaceutical industry, and patient organisations) in public-private partnerships for product development in Alzheimer’s disease and other dementias.

    Related Documents
  • 25-September-2014

    English

    Nanotechnology in the Context of Technology Convergence

    This report explores the characteristics of nanotechnology as it relates to technology convergence i.e. actual instances of the convergence of different technology streams in the research and innovation environments within laboratories and companies. It examines four application areas in which nanotechnology plays a strong role (green packaging, food safety and security, pharmaceuticals and medical devices).

    Related Documents
  • 23-September-2014

    English

    Biobased Chemicals and Bioplastics: Finding the Right Policy Balance

    Several OECD countries have published their plans for the development of a future bioeconomy, in which bio-based materials and production techniques will contribute significantly to economic and environmental sustainability. The case for support for bio-based chemicals and plastics therefore warrants serious attention.

    Related Documents
  • 4-June-2014

    English

    Emerging Policy Issues in Synthetic Biology

    Synthetic biology is an emerging technology that shows promise for investigating some of the burning issues in biological research. It also has the potential to address some of the grand challenges facing society, such as climate change and energy security.

    Related Documents
  • 12-February-2014

    English, PDF, 566kb

    Considerations in Moving towards a Statistical Framework for Nanotechnology

    This report presents findings from a pilot survey of business activity in nanotechnology and discusses methodological and practical issues (e.g. the use of definitions) for on-going consideration in work on statistics and indicators for nanotechnology. It identifies how work in this area may support the assessment of other emerging technologies via an integrated framework.

    Related Documents
  • 5-December-2013

    English

    Toward New Models for Innovative Governance of Biomedicine and Health Technologies

    This report examines examples of new and emerging governance models that aim to support the responsible development of diagnostics and treatments based on the latest advances in biomedicine. In particular, it presents programmes and initiatives that aim to manage uncertainty in the development and approval of new medical products and thereby to improve the understanding of the risk/benefit balance.

    Related Documents
  • 14-November-2013

    English

    Emerging Trends in Biomedicine and Health Technology Innovation: Addressing the Global Challenge of Alzheimer's

    The economic and social impact of chronic brain disorders such as Alzheimer’s disease and other neurodegenerative diseases will become the number one public-health problem worldwide, directly affecting 100 million people by 2050.

    Related Documents
  • 28-October-2013

    English

    Policies for Bioplastics in the Context of a Bioeconomy

    This paper explores the development of the bioplastics sector and its role in national bioeconomy strategies. It finds that bioplastics are at a disadvantage compared to some other biobased products, notably biofuels, that often benefit from preferential treatment. It also notes that greater efforts are needed at the international level as regards standards to avoid creating barriers to international trade in biobased products.

    Related Documents
  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>